7 May 2020: The DNA & gene chip market is expected to grow due to its ability to provide high throughput capabilities for comprehensive genome studies. It underlines the importance of the DNA microarray technology and has helped in gaining insights on various diseases. Large numbers of nucleic acid fragments can be analyzed using DNA microarray technology in a single experiment. In order to further enhance reliability of this technology, continuous development of new tools is required, which is likely to drive this market in coming years.
Microarray to Assist in Gene Studies
Based on products, consumables held the largest share in the DNA & gene chip market in 2017 and the segment is likely to grow over the forecast period. Due to availability of reagents and technological advancements along with availability of ancillary components the gene expression data analysis algorithms is becoming easy to implement a microarray procedure.
Instruments segment in the microarrays are anticipating exponential growth of DNA & gene chip over the forecast period due to introduction of new instruments that are proving assistance in gene. For instance, in November 2016, for the purpose of diagnostic and research, Applied Micro Arrays announced Innopsys range of microarray scanners.
There has been a growing need for solutions to classify vast information into a usable form that has occurred due to massive DNA sequence information generated by the Human Genome Project and gene expression studies. The DNA & gene chip technology provides speeding clinical utility of genomic information efficiently aiding in creating public databases.
High demand for applications of DNA & gene chip microarrays in biomedicine has resulted in manufacturers; increasing inclination towards development of novel solutions for analysis and storage of microarray-generated data.
Market Insights
The growth of this technology is due to characteristics of DNA & gene chip microarrays to analyze genes. Demand in clinical laboratories along with advancements in method of fabrication, robotics, and computational capabilities for microarrays have fueled the market growth.
Research collaborations are helping the technology gain more grounds in genomics. For instance, in February 2016, Illumina, Inc. signed agreements for biobanking with Montreal Heart Institute, Partners HealthCare, University of Colorado, and Vanderbilt University.
Some of the major players of the DNA & gene chip market are Microarrays Inc; Agilent Technologies; Thermo Fisher Scientific, Inc. (Affymetrix, Inc.); CapitalBio Corporation, Perkin Elmer, Inc.; Illumina, Inc.; Asper Biotech; Arrayit Corporation; Macrogen Inc.; and Greiner Bio One International GmbH.
No comments:
Post a Comment